Global Next Generation Cancer Diagnostics Market Analysis 2013-2018 and Forecast 2019-2024

Scope

Table of Content

1 Industry Overview

1.1 Next Generation Cancer Diagnostics Industry

1.1.1 Overview

1.1.2 Development of Next Generation Cancer Diagnostics

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Next Generation Cancer Diagnostics Market by Type

3.1 By Type

3.1.1 Next Generation Sequencing

3.1.2 qPCR & Multiplexing

3.1.3 DNA Microarrays

3.1.4 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.1 Cepheid (Company Profile, Sales Data etc.)

4.2 Koninklijke Philips N.V (Company Profile, Sales Data etc.)

4.3 F. Hoffmann-La Roche Ltd (Company Profile, Sales Data etc.)

4.4 Qiagen (Company Profile, Sales Data etc.)

4.5 Novartis AG (Company Profile, Sales Data etc.)

4.6 Abbott (Company Profile, Sales Data etc.)

4.7 Thermo Fisher Scientific (Company Profile, Sales Data etc.)

4.8 Opko Health (Company Profile, Sales Data etc.)

4.9 Myriad Genetics (Company Profile, Sales Data etc.)

4.10 Agilent Technologies (Company Profile, Sales Data etc.)

4.11 GE Healthcare (Company Profile, Sales Data etc.)

4.12 PerkinElmer (Company Profile, Sales Data etc.)

4.13 Genomic Health (Company Profile, Sales Data etc.)

4.14 Illumina (Company Profile, Sales Data etc.)

4.15 Hologic (Company Profile, Sales Data etc.)

4.16 Almac Group (Company Profile, Sales Data etc.)

4.17 Janssen Global Services (Company Profile, Sales Data etc.)

4.18 Sysmex Corporation (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Market Demand

6.1 Demand Situation

6.1.1 Demand in Hospitals

6.1.2 Demand in Clinics

6.1.3 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion

List Of Figure

Figure Next Generation Cancer Diagnostics Industry Chain Structure

Figure Global Next Generation Cancer Diagnostics Market Growth 2013-2018, by Type, in USD Million

Figure North America Next Generation Cancer Diagnostics Market, by Company, in 2018

Figure Europe Next Generation Cancer Diagnostics Market Market, by Company, in 2018

Figure Asia-Pacific Next Generation Cancer Diagnostics Market Market, by Company, in 2018

Figure South America Next Generation Cancer Diagnostics Market Market, by Company, in 2018

Figure Middle East & Africa Next Generation Cancer Diagnostics Market Market, by Company, in 2018

Figure North America Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million

Figure Europe Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million

Figure South America Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million

Figure Marketing Channels Overview

List Of Table

Table Upstream Segment of Next Generation Cancer Diagnostics

Table Application Segment of Next Generation Cancer Diagnostics

Table Global Next Generation Cancer Diagnostics Market 2013-2024, by Application, in USD Million

Table Major Company List of Next Generation Sequencing

Table Major Company List of qPCR & Multiplexing

Table Major Company List of DNA Microarrays

Table Major Company List of Others

Table Global Next Generation Cancer Diagnostics Market 2013-2018, by Type, in USD Million

Table Global Next Generation Cancer Diagnostics Market Forecast 2019-2024, by Type, in USD Million

Table Cepheid Overview List

Table Next Generation Cancer Diagnostics Business Operation of Cepheid (Sales Revenue, Cost, Gross Margin)

Table Koninklijke Philips N.V Overview List

Table Next Generation Cancer Diagnostics Business Operation of Koninklijke Philips N.V (Sales Revenue, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd Overview List

Table Next Generation Cancer Diagnostics Business Operation of F. Hoffmann-La Roche Ltd (Sales Revenue, Cost, Gross Margin)

Table Qiagen Overview List

Table Next Generation Cancer Diagnostics Business Operation of Qiagen (Sales Revenue, Cost, Gross Margin)

Table Novartis AG Overview List

Table Next Generation Cancer Diagnostics Business Operation of Novartis AG (Sales Revenue, Cost, Gross Margin)

Table Abbott Overview List

Table Next Generation Cancer Diagnostics Business Operation of Abbott (Sales Revenue, Cost, Gross Margin)

Table Thermo Fisher Scientific Overview List

Table Next Generation Cancer Diagnostics Business Operation of Thermo Fisher Scientific (Sales Revenue, Cost, Gross Margin)

Table Opko Health Overview List

Table Next Generation Cancer Diagnostics Business Operation of Opko Health (Sales Revenue, Cost, Gross Margin)

Table Myriad Genetics Overview List

Table Next Generation Cancer Diagnostics Business Operation of Myriad Genetics (Sales Revenue, Cost, Gross Margin)

Table Agilent Technologies Overview List

Table Next Generation Cancer Diagnostics Business Operation of Agilent Technologies (Sales Revenue, Cost, Gross Margin)

Table GE Healthcare Overview List

Table Next Generation Cancer Diagnostics Business Operation of GE Healthcare (Sales Revenue, Cost, Gross Margin)

Table PerkinElmer Overview List

Table Next Generation Cancer Diagnostics Business Operation of PerkinElmer (Sales Revenue, Cost, Gross Margin)

Table Genomic Health Overview List

Table Next Generation Cancer Diagnostics Business Operation of Genomic Health (Sales Revenue, Cost, Gross Margin)

Table Illumina Overview List

Table Next Generation Cancer Diagnostics Business Operation of Illumina (Sales Revenue, Cost, Gross Margin)

Table Hologic Overview List

Table Next Generation Cancer Diagnostics Business Operation of Hologic (Sales Revenue, Cost, Gross Margin)

Table Almac Group Overview List

Table Next Generation Cancer Diagnostics Business Operation of Almac Group (Sales Revenue, Cost, Gross Margin)

Table Janssen Global Services Overview List

Table Next Generation Cancer Diagnostics Business Operation of Janssen Global Services (Sales Revenue, Cost, Gross Margin)

Table Sysmex Corporation Overview List

Table Next Generation Cancer Diagnostics Business Operation of Sysmex Corporation (Sales Revenue, Cost, Gross Margin)

Table Global Next Generation Cancer Diagnostics Sales Revenue 2013-2018, by Company, in USD Million

Table Global Next Generation Cancer Diagnostics Sales Revenue Share, by Company, in USD Million

Table Next Generation Cancer Diagnostics Demand in Hospitals, 2013-2018, in USD Million

Table Major Consumers in Hospitals

Table Next Generation Cancer Diagnostics Demand in Clinics, 2013-2018, in USD Million

Table Major Consumers in Clinics

Table Next Generation Cancer Diagnostics Demand in Others, 2013-2018, in USD Million

Table Major Consumers in Others

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Next Generation Cancer Diagnostics Demand Forecast 2019-2024, by Application, in USD Million

Table Next Generation Cancer Diagnostics Production 2013-2018, by Region, in USD Million

Table Global Next Generation Cancer Diagnostics Market 2013-2018, by Region, in USD Million

Table Global Next Generation Cancer Diagnostics Market Share 2013-2018, by Region, in USD Million

Table North America Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million

Table Europe Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million

Table South America Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million

Table Next Generation Cancer Diagnostics Market Forecast 2019-2024, by Region, in USD Million

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"